chuminhua2019-10-23 23:33
10/22,Trovagene公$Trovagene(TROV)$ 宣布,其在研PLK1抑制剂onvansertib(PCM-075),与Folfiri,Avastin(bevacizumab)联合,作为二线疗法在治疗携带KRAS基因突变的转移性结直肠癌(CRC)患者的1b/2期临床试验中,取得积极的试验初期数据。在第一批患者的分析中,观察到肿瘤KRAS基因突变负荷水...查看全文
牛唐2019-08-21 14:21
$Ardelyx(ARDX)$ $Trovagene(TROV)$ 放量上涨的runup走势,9月13号,ARDX的药物Ibresla在IBS适应症方面会有审批,9月底前计划公布高磷酸盐血症方面的三期topline data;trov是在8月24日计划公布 Onvansertib 与Zytiga的二期数据$复星医药(SH600196)$查看全文
越炒股越美2019-04-25 14:53
【汇众医疗】4月23日医药股盘点:6支生物制药股势头强劲,上涨幅度均高于15%
$Atossa Genetics(ATOS)$$Trovagene(TROV)$ $Athersys(ATHX)$ 4月23日股市收盘时,6支生物制药公司股票上涨,涨幅均高于15%。而研发乳腺癌药物的Atossa Genetics以3.48美元收盘,上涨22.97%,涨幅最大。研究罕见病药...查看全文
$TrovaGene, Inc.(TROV)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2018-06-04 AccNo: 0001193125-18-183474 Size: 8 MB 网页链接
$TrovaGene, Inc.(TROV)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2018-06-04 AccNo: 0001193125-18-183474 Size: 8 MB 网页链接
$TrovaGene, Inc.(TROV)$ 美东时间 2018-06-04 拆合股: 12合1 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-06-01 AccNo: 0001193125-18-181824 Size: 41 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-05-30 AccNo: 0001104659-18-036749 Size: 56 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-05-17 AccNo: 0001193125-18-165972 Size: 42 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2018-05-10 AccNo: 0001193125-18-157775 Size: 1 MB 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-05-09 AccNo: 0001193125-18-156817 Size: 99 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-08 AccNo: 0001628280-18-006233 Size: 3 MB 网页链接
$TrovaGene, Inc.(TROV)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-27 AccNo: 0001193125-18-139038 Size: 492 KB 网页链接